Legacy Treatment Services Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 610 Pemberton Browns Mills Rd, Pemberton, NJ 08068 Phone: 609-726-7155 Fax: 609-894-8964 |
Merakey New Jersey Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 152 Oak Pines Blvd, Pemberton, NJ 08068 Phone: 215-836-3131 Fax: 215-273-5975 |
Exceptional Kidz Rehabilitation Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 43 Elizabeth St, Pemberton, NJ 08068 Phone: 609-316-0195 Fax: 609-353-1549 |
Legacy Treatment Services Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 610 Pemberton Browns Mills Rd, Pemberton, NJ 08068 Phone: 609-726-7155 Fax: 609-894-8964 |
News Archive
New research may allow new, more effective and safer pain medications to reach patients who suffer from chronic pain sooner. According to a recent study published in Anesthesiology, the official medical journal of the American Society of Anesthesiologists, using functional magnetic resonance imaging (FMRI), to measure the brain's neural response to pain, may be a viable tool for evaluating the effectiveness of new pain medications during the early stages of human drug development - providing the needed objective evidence to prevent the premature discarding of potentially beneficial therapies.
The Obama administration wrote a new chapter Wednesday in the "if you like your health plan, you can keep it" chronicles, decreeing that plans it once derided as "junk" or "substandard" can remain in effect until October 2017 - long after the next presidential election. The point, administration officials say, is to help those in the market for individual or small-group plans make a smoother transition into Obamacare (Jon Healey, 3/5).
Jenny Craig, Inc., one of the leading authorities on weight management, is launching a new male-targeted initiative titled "Jen Works for Men" with celebrity spokesperson Jason Alexander as the face of the new campaign. Alexander, who famously lost 30 pounds on the program, wrote, directed and starred in the new series of national commercials for the weight loss company, slated to launch on Monday, February 21, 2011.
Orexigen® ( )Therapeutics, Inc today announced new data from the COR-I, COR-II and COR-Diabetes trials for Contrave® (bupropion SR/ naltrexone SR) to expand on top-line results announced in July. Contrave is the first of the Company's two late stage candidates for the treatment of obesity.
A multi-site study published in The Journal of Pain showed a wide range of pain intensity scores in hospitalized infants and a significant number of them were found to have moderate to severe pain during their hospital stays.
› Verified 8 days ago